First published online March 14, 2005
Journal of Experimental Biology 208, 1095-1107 (2005)
Published by The Company of Biologists 2005
doi: 10.1242/jeb.01480
Cardiorespiratory responses to hypercarbia in tambaqui Colossoma macropomum: chemoreceptor orientation and specificity
K. M. Gilmour1,2,*,
W. K. Milsom1,3,
F. T. Rantin1,
S. G. Reid1,4 and
S. F. Perry1,2
1 Department of Physiological Sciences, Federal University of São
Carlos, Via Washington Luiz km 235, São Carlos, SP, 13565-905,
Brazil
2 Department of Biology, University of Ottawa, 150 Louis Pasteur, Ottawa,
ON, K1N 6N5 Canada
3 Department of Zoology, University of British Columbia, Vancouver, BC, V6T
1Z4 Canada
4 Department of Life Sciences, University of Toronto at Scarborough,
Toronto, ON, M1C 1A4 Canada

View larger version (31K):
[in a new window]
|
Fig. 1. The effects of stepwise increases in water PCO2
(PwCO2) followed by the rapid lowering of
PwCO2 (A) on ventilation, blood gases, and acid-base
status in tambaqui Colossoma macropomum, including (B) ventilation
amplitude (VAMP; N=9-11), (C) ventilation
frequency (fV; N=8-9), (D) arterial
PCO2 (PaCO2; N=8-9), (E)
arterial PO2 (PaO2; N=7-8)
and (F) arterial pH (pHa; N=8-9). Pre1 and Pre2 refer to pre-exposure
values compiled 2 min and immediately, respectively, before the onset of
hypercarbia; the numbers 7, 16 and 26 denote values compiled for the final 2
min of the three discrete steps of increasing hypercarbia; and the data
plotted to the right of the break in the x-axis represent values
compiled for 2 min intervals after the initiation of rapid washout of
CO2 at 0 min. The data are presented as means ± 1
S.E.M. For stepwise increases in
PwCO2, values that do not share a letter are significantly
different from one another (one-way RM-ANOVA, P<0.001 for B-D and
F; P=0.001 for E). For the rapid washout of water CO2,
asterisks indicate values that are significantly different from the value at
time=0 min (one-way RM-ANOVA, P<0.001 for all).
|
|

View larger version (34K):
[in a new window]
|
Fig. 2. The effects of stepwise increases in water PCO2
(PwCO2) followed by the rapid lowering of
PwCO2 (A) on cardiovascular variables in tambaqui
Colossoma macropomum including (B) arterial blood pressure
(PDA; N=10-11), (C) systemic vascular resistance
(Rs; N=9-10), (D) cardiac output
( b; N=8-10), (E) heart rate
(fH; N=9-11) and (F) cardiac stroke volume
(VS; N=9-10). Data for PaCO2
are replotted from Fig. 1 in A
for ease of comparison. Pre1 and Pre2 refer to pre-exposure values compiled 2
min and immediately, respectively, before the onset of hypercarbia; the
numbers 7, 16 and 26 denote values compiled for the final 2 min of the three
discrete steps of increasing hypercarbia; and the data plotted to the right of
the break in the x-axis represent values compiled for 2 min intervals
after the initiation of rapid washout of CO2 at 0 min. The data are
presented as means ± 1 S.E.M. For
stepwise increases in PwCO2, values that do not share a
letter are significantly different from one another (one-way RM-ANOVA;
P values: B, 0.386; C, 0.892; D, 0.144; E and F, <0.001). For the
rapid washout of water CO2, asterisks indicate values that are
significantly different from the value at time=0 min (one-way RM-ANOVA,
P values: B, 0.444; C, 0.002; D-F, <0.001).
|
|

View larger version (28K):
[in a new window]
|
Fig. 3. The effects of acetazolamide (Az) injection followed by hypercarbia
(PwCO2=13.6 mmHg) and the rapid lowering of
PwCO2 (A) on ventilation and blood gas and acid-base
status in tambaqui Colossoma macropomum, including (B) ventilation
amplitude (VAMP; N=8), (C) ventilation frequency
(fV; N=8), (D) arterial PCO2
(PaCO2; N=8), (E) arterial
PO2 (PaO2; N=6-7), and (F)
arterial pH (pHa; N=8). Acetazolamide was injected at time=0 min,
while the onset of hypercarbia and rapid water CO2 washout are
designated by the vertical broken lines. Values are means ± 1
S.E.M. Significant differences from the
pre-injection (time=0 min) or pre-hypercarbic exposure (time= 35 min) values
are indicated by an asterisk (one-way RM-ANOVA; P values for
acetazolamide treatment and hypercarbia, respectively: B, 0.127 and 0.002; C,
0.569 and <0.001; D, <0.001 for both; E, 0.241 and 0.028; F, <0.001
for both). For the rapid lowering of PwCO2, significant
differences from the initial value (time=50 min) are indicated by an asterisk
or double-arrowhead line (one-way RM-ANOVA with P values <0.001
for all).
|
|

View larger version (32K):
[in a new window]
|
Fig. 4. The effects of acetazolamide (Az) injection followed by hypercarbia
(PwCO2=13.6 mmHg) and the rapid lowering of
PwCO2 (A) on cardiovascular variables in tambaqui
Colossoma macropomum, including (B) arterial blood pressure
(PDA; N=7-8), (C) systemic vascular resistance
(Rs; N=6-7), (D) cardiac output
( b; N=7), (E) heart rate
(fH; N=8), and (F) cardiac stroke volume
(VS; N=7). Data for PaCO2 are
replotted from Fig. 3 in A for
ease of comparison. Acetazolamide was injected at time=0 min, while the onset
of hypercarbia and rapid water CO2 washout are designated by the
vertical broken lines. Values are means ± 1
S.E.M. Significant differences from the
pre-injection (time= 0 min) or pre-hypercarbic exposure (time=35 min) values
are indicated by an asterisk (one-way RM-ANOVA; P values for
acetazolamide treatment and hypercarbia, respectively: B, 0.248 and 0.045; C,
0.050 and 0.116; D, 0.016 and 0.134; E, 0.291 and 0.012; F, 0.038 and 0.006).
For the rapid lowering of PwCO2, significant differences
from the initial value (time= 50 min) are indicated by an asterisk or
double-arrowhead line (one-way RM-ANOVA with P values: B, 0.281; C,
0.107; D, 0.011; E, 0.042; F, 0.017).
|
|

View larger version (33K):
[in a new window]
|
Fig. 5. Representative data acquisition traces illustrating the lack of
correspondence between changes in arterial PCO2
(PaCO2; red trace, A), and those in ventilation, presented
as the raw impedance trace (grey, B) overlain by the calculated ventilation
amplitude (VAMP) trace (black line, B). Rather, as the
yellow area emphasizes, ventilation tracked changes in water
PCO2 (PwCO2; black line, B).
|
|
© The Company of Biologists Ltd 2005